Trial intelligence / Profile preview

Vitamin D Supplementation in Adults With NF1

NCT01968590Phase 2Terminated

Sponsor
University of Utah
Start
Aug 2017
Primary completion
Jan 2022
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
2
01

Overview

A Phase 2 trial of vitamin d in neurofibromatosis type 1 (NF1), sponsored by University of Utah. Started Aug 2017; status: terminated.

02

Drugs

vitamin d
03

Conditions

neurofibromatosis type 1 (NF1)

Beyond the preview

Go deeper on NCT01968590.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01968590.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call